Methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
C51H54N8O6 — CID 146518475
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
Methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (PubChem CID 146518475) has the molecular formula C51H54N8O6 and a molecular weight of 875.04 g/mol. Its IUPAC name is methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
|---|---|
| PubChem CID | 146518475 |
| Molecular Formula | C51H54N8O6 |
| Molecular Weight | 875.04 g/mol |
| Exact Mass | 874.42 |
| IUPAC Name | methyl N-[(1R)-2-[(2S)-2-[7-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-4,5-dihydro-3H-benzo[e]benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
| SMILES | COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4ccc5c(c4)CCc4[nH]c([C@@H]6CCCN6C(=O)[C@H](NC(=O)OC)c6ccccc6)nc4-5)cc3)cc2)[nH]1)C(C)C |
| InChI | InChI=1S/C51H54N8O6/c1-30(2)43(56-50(62)64-3)48(60)58-26-8-12-41(58)46-52-29-40(54-46)34-20-18-32(19-21-34)31-14-16-33(17-15-31)36-22-24-38-37(28-36)23-25-39-45(38)55-47(53-39)42-13-9-27-59(42)49(61)44(57-51(63)65-4)35-10-6-5-7-11-35/h5-7,10-11,14-22,24,28-30,41-44H,8-9,12-13,23,25-27H2,1-4H3,(H,52,54)(H,53,55)(H,56,62)(H,57,63)/t41-,42-,43-,44+/m0/s1 |
| InChIKey | OQAPXVHVPVIUJL-LNYMGSRYSA-N |
| XLogP | 8.70 |
| TPSA | 174.64 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 65 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 875.04 |
| LogP ≤ 5 | 8.70 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146518475 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.